Evidence map›Paper›PMID 39911510›Full record

ArticleAntimicrobial stewardship & healthcare epidemiology : ASHE2025

Correlation between carbapenem susceptibility in

Keisuke Sawada, Takaaki Kato, Shuji Kono, Hiromi Kaneko, Hayato Nakano, Shinobu Inada, Tatsuya Isogawa, Tadahiro Shimizu, Namiko Takahashi, Haruki Takano and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antimicrobial stewardship & healthcare epidemiology : ASHE, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Keisuke SawadaDepartment of Pharmacy, Federation of National Public Service Personnel Mutual Aid Associations Hirakata Kohsai Hospital, Osaka, Japan.ORCID https://orcid.org/0000-0001-7102-215X
Takaaki KatoDepartment of Infection Control and Prevention, Federation of National Public Service Personnel Mutual Aid Associations Hirakata Kohsai Hospital, Osaka, Japan.
Shuji KonoDepartment of Pharmacy, Federation of National Public Service Personnel Mutual Aid Associations Hirakata Kohsai Hospital, Osaka, Japan.
Hiromi KanekoNational Public Service Personnel Mutual Aid Associations, Tokyo, Japan.
Hayato NakanoDepartment of Infection Control and Prevention, Federation of National Public Service Personnel Mutual Aid Associations Hiroshima Memorial Hospital, Hiroshima, Japan.
Shinobu InadaDepartment of Infection Control and Prevention, Federation of National Public Service Personnel Mutual Aid Associations Shinbeppu Hospital, Oita, Japan.
Tatsuya IsogawaDepartment of Infection Control and Prevention, Federation of National Public Service Personnel Mutual Aid Associations Shinbeppu Hospital, Oita, Japan.
Tadahiro ShimizuDepartment of Infection Control and Prevention, Federation of National Public Service Personnel Mutual Aid Associations Mishuku Hospital, Tokyo, Japan.
Namiko TakahashiDepartment of Infection Control and Prevention, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Haruki TakanoDepartment of Infection Control and Prevention, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.
Hiroaki ChibaDepartment of Infection Control and Prevention, Federation of National Public Service Personnel Mutual Aid Associations Tohoku Kosai Hospital, Miyagi, Japan.
Makoto SugimotoDepartment of Infection Control and Prevention, Federation of National Public Service Personnel Mutual Aid Associations Yokosuka Kyosai Hospital, Kanagawa, Japan.
Ryo InoseLaboratory of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Kyoto, Japan.ORCID https://orcid.org/0000-0003-4874-0377
Yuichi MurakiLaboratory of Clinical Pharmacoepidemiology, Kyoto Pharmaceutical University, Kyoto, Japan.ORCID https://orcid.org/0000-0001-6951-5676
Hideki AraokaDepartment of Infection Control and Prevention, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study focused on exploring the relationship between antimicrobial use indicators, including the modified antibiotic heterogeneity index (mAHI), and the carbapenem susceptibility in Design: Survey-based observational study conducted across multiple facilities. Setting: Public community hospital institutions. Methods: This survey was conducted in 15 community hospitals in Japan. Indicators, such as the defined daily doses (DDDs), days of therapy (DOTs), antibiotic heterogeneity index (AHI), and mAHI, were analyzed for Results: No significant correlations were observed between DDDs or DOTs and carbapenem susceptibility. However, a significant correlation was observed between carbapenem susceptibility and the mAHI ( Conclusions: The mAHI may be a better predictor of carbapenem susceptibility than other commonly used indicators. This study underscores the utility of the mAHI as an effective indicator of antimicrobial usage patterns for managing carbapenem susceptibility in

Identifiers

PMID39911510
PMCPMC11795433

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.